Cat. No. | Product name | CAS No. |
DC7050 |
ADL5859 HCl
Featured
ADL5859 agonizes δ-opioid receptor with a 1000-fold selectivity than µ- or κ-opioid receptor with Ki of 32 nM and 37 nM, respectively.ADL5859 displays weak inhibitory activity at the hERG channel with an IC50 of 78 μM. The EC50 of ADL5859 against δ opioid |
850173-95-4 |
DC8606 |
Alvimopan monohydrate
Alvimopan(LY 246736; ADL 8-2698) is a peripherally acting mu-opioid receptor (PAM-OR, IC50= 1.7 nM) antagonist for accelerating gastrointestinal recovery after surgery. |
1383577-62-5 |
DC8605 |
Alvimopan dihydrate
Alvimopan(LY 246736; ADL 8-2698) is a peripherally acting mu-opioid receptor (PAM-OR, IC50= 1.7 nM) antagonist for accelerating gastrointestinal recovery after surgery. |
170098-38-1 |
DC8298 |
BAN ORL 24
Featured
BAN ORL 24 is a potent, selective, competitive ORL1 non-peptide agonist. Displays 1000-fold selectivity over classical opioid receptors. |
1401463-54-4 |
DC7097 |
Cebranopadol(GRT-6005)
Featured
branopadol(GRT-6005) is a novel first in class compounds with potent agonist activity on ORL-1 (opioid receptor like -1) and the well established mu opioid receptor. |
863513-91-1 |
DC10945 |
BU09059
BU09059 is a potent, selective, short-acting kappa-opioid receptor antagonist with Ki of 1.72 nM, displays 15- and 616-fold selectivity over μ- and δ-receptors respectively. |
1541206-05-6 |
DC9765 |
CERC-501(LY-2456302,Aticaprant)
Featured
CERC-501(LY-2456302) is a potent, selective antagonist of the kappa opioid receptor (KOR) (Ki = 0.81 nM vs. 24.0 nM and 155 nM for the μ-opioid receptor (MOR) and δ-opioid receptor (DOR), respectively. |
1174130-61-0 |
DC8626 |
Eluxadoline
Featured
Eluxadoline is an orally active mixed μ opioid receptor (μOR) agonist δ opioid receptor (δOR) antagonist. |
864821-90-9 |
DC9524 |
JDTic (dihydrochloride)
JDTic 2Hcl is a highly selective antagonist for the κ-opioid receptor; without affecting the μ- or δ-opioid receptors. |
785835-79-2 |
DC9526 |
Meptazinol (hydrochloride)
Featured
Meptazinol Hcl(WY-22811 Hcl) is a unique centrally active opioid analgesic. |
59263-76-2 |
DC9527 |
Methylnaltrexone (Bromide)
Featured
Methylnaltrexone Bromide is a pheriphally-acting μ-opioid antagonist that acts on the gastrointestinal tract to decrease opioid-induced constipation. |
73232-52-7 |
DC11171 |
NFEPP
NFEPP is a novel potent, selective pH-dependent μ-opioid receptor (MOR) agonist with a low pKa, shows significantly lower affinity compared with fentanyl at pH 7.4. |
1422952-82-6 |
DC10290 |
PZM21
Featured
PZM21 is a potent and selective μ opioid receptor agonist with an EC50 of 1.8 nM. |
1997387-43-5 |
DC7439 |
JTC-801
JTC-801 is a selective opioid receptor-like1 (ORL1) receptor antagonist with IC50 of 94 nM, weakly inhibits receptors δ, κ, and μ. |
244218-51-7 |
DC28211 |
Naloxone benzoylhydrazone
Naloxone benzoylhydrazone (NalBzoH) is a mixed agonist/antagonist. Naloxone benzoylhydrazone is a prototypic κ3-opioid receptor agonist, and a partial agonist at the cloned μ and δ opioid receptors, and an antagonist at opioid-like NOP receptors. Naloxone benzoylhydrazone has potently analgesia effect. |
119630-94-3 |
DC28515 |
Hecogenin acetate
Hecogenin acetate is a steroidal sapogenin-acetylated with anti-inflammatory and antinociceptive. Hecogenin acetate shows potential antihyperalgesic activity, inhibiting descending pain and acting in opioid receptors. |
915-35-5 |
DC28780 |
LY2444296
Featured
LY2444296 is an orally bioavailable, high-affinity and selective short-acting kappa opioid receptor (KOPR) antagonist, with a Ki value of ∼1 nM. LY2444296 exhibits anti-anxiety like effects. |
1346133-11-6 |
DC29090 |
β-Casomorphin, bovine TFA
β-Casomorphin, bovine TFA (β-Casomorphin-7 (bovine) TFA) is a opioid peptide with an IC50 of 14 μM in an Opioid receptors binding assay. |
|
DC29117 |
β-Casomorphin, human TFA
β-Casomorphin, human TFA (Human β-casomorphin 7 TFA) is an opioid peptide, acts as an agonist of opioid receptor. |
|
DC40135 |
Trap-101 hydrochloride
Trap-101 hydrochloride is a potent, selective and competitive antagonist of NOP receptors over classical opioid receptors. Trap-101 stimulates GTPγ35S binding to CHOhNOP membranes with pKi values of 8.65, 6.60, 6.14 and <5 for NOP,?μ-,?κ-, and?δ-opioid receptors, respectively. Trap-101 attenuates motor deficits in a rat model of parkinson's disease and can be used for the research of nervous?system?diseases. |
1216621-00-9 |
DC40852 |
TAN-452
TAN-452 is an orally active, selective peripherally acting δ-opioid receptor (DOR) antagonist with a Ki of 0.47?nM and a Kb of 0.21?nM. TAN-452 is an antagonist for μ-opioid receptor (MOR; Ki=36.56?nM and Kb=9.43?nM) and κ-opioid receptor (KOR; Ki=5.31?nM and Kb=7.18?nM). TAN-452, a derivative of Naltrindole, demonstrates low brain penetrability and attenuates morphine-induced side effects without affecting pain control. |
892039-23-5 |
DC40982 |
Loperamide phenyl
Loperamide phenyl is an impurity of Loperamide. Loperamide is an opioid receptor agonist. |
1391052-94-0 |